# US Blockchain Pharmaceutical Supply Chain Management Market > US Blockchain Pharmaceutical Supply Chain Management Market Research Report By Application (Product Traceability, Risk & Compliance Management, Payment & Settlement, Others) and By End User (Manufacturers, Distributors, Healthcare Providers) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 21.07% - **2024:** $ 253.13 Million - **2025:** $ 306.47 Million - **2035:** $ 2,074.72 Million - **Key Players:** IBM (US), Modum (CH), Chronicled (US), VeChain (CN), Waltonchain (CN), MediLedger (US), Acoer (US), PharmaLedger (EU) **Report ID:** MRFR/Pharma/17767-HCR · **Pages:** 100 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-blockchain-pharmaceutical-supply-chain-management-market-19314 --- ## Market Summary ## **US Blockchain Pharmaceutical Supply Chain Management Market Overview** As per MRFR analysis, the US Blockchain Pharmaceutical Supply Chain Management Market Size was estimated at 274.4 (USD Million) in 2023. The US Blockchain Pharmaceutical Supply Chain Management Market Industry is expected to grow from 337.51(USD Million) in 2024 to 948.72 (USD Million) by 2035. The US Blockchain Pharmaceutical Supply Chain Management Market CAGR (growth rate) is expected to be around 9.851% during the forecast period (2025 - 2035). ### **Key US Blockchain Pharmaceutical Supply Chain Management Market Trends Highlighted** The US Blockchain Pharmaceutical Supply Chain Management market is gaining momentum due to several key market drivers. A primary driver is the growing emphasis on securing the drug supply chain against counterfeiting. The Drug Supply Chain Security Act mandates enhanced security and traceability of pharmaceuticals, prompting companies to seek innovative solutions. Blockchain technology offers a robust solution, providing transparency and security by creating an immutable ledger for tracking drug shipments. The increasing regulatory push for compliance with stringent standards also drives the market, as blockchain can facilitate adherence to these regulations efficiently. There are several opportunities within the US market that firms can explore to capitalize on blockchain integration. By adopting this technology, pharmaceutical companies can enhance supply chain efficiency, reduce operational costs, and improve inventory management. This shift can enable stakeholders to gain real-time insights into their supply chains, leading to more informed decision-making. Additionally, collaboration between pharmaceutical companies and technology providers presents an avenue for innovation, allowing for the development of tailored solutions for specific challenges within the supply chain. Recent trends indicate an increasing interest in pilot programs and partnerships focusing on blockchain within the pharmaceutical industry in the US. Major pharmaceutical firms and technology companies are actively exploring blockchain applications through trials and collaborations. Furthermore, educational initiatives aimed at increasing awareness and understanding of blockchain technology among industry stakeholders are becoming more prevalent. These trends signal a collective movement towards more secure and efficient drug supply chains, marking significant progress in the integration of blockchain technology in the US pharmaceutical sector. As the industry evolves, the adoption of blockchain is likely to reshape how supply chains are managed, enhancing transparency and trust among consumers and healthcare providers alike. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Blockchain Pharmaceutical Supply Chain Management Market Drivers** ### **Increase in Counterfeit Drug Incidences** The growing concern over the prevalence of counterfeit drugs in the United States has significantly contributed to the demand for blockchain technology in pharmaceutical [supply chain management](../../../reports/supply-chain-management-market-21742). According to the National Association of Boards of Pharmacy, approximately 10% of pharmaceuticals sold globally are counterfeit, and in the U.S., that figure is rising. The Drug Enforcement Administration has reported an increase in seizures of counterfeit medications, emphasizing the need for more robust tracking and verification systems. Blockchain technology can provide immutable records of drug transactions, ensuring the authenticity of pharmaceuticals. Major entities like the Food and Drug Administration (FDA) advocate for advanced technologies to combat counterfeiting, which further solidifies the case for the growth of the US Blockchain Pharmaceutical Supply Chain Management Market Industry as pharmaceutical companies seek to enhance security and traceability in their supply chains. ### **Regulatory Compliance Requirements** Increasing regulatory compliance requirements in the pharmaceutical industry are driving the adoption of blockchain technology for supply chain management. The FDA's Drug Supply Chain Security Act mandates that pharmaceutical companies implement measures to enhance traceability and verify product authenticity. As a result, organizations are turning to blockchain to streamline compliance, as it provides a secure and transparent method of documenting the supply chain process. By employing blockchain systems, stakeholders can improve their adherence to regulations, avoiding potential fines and legal issues. This aspect is particularly significant in the US Blockchain Pharmaceutical Supply Chain Management Market Industry, where maintaining compliance is critical for operational continuity and public trust. ### **Growing Demand for Enhanced Transparency** The push for greater transparency in the pharmaceutical supply chain is a key driver for blockchain adoption in the sector. Industry leaders and organizations are increasingly recognizing the importance of sharing data among stakeholders to foster trust and accountability. A recent report by the World Health Organization indicated that transparency in the supply chain can reduce medication errors by nearly 50%. Given that the US experiences an alarming number of medication errors, organizations are incentivized to adopt blockchain solutions that streamline access to accurate data and enhance communication. This trend supports the future growth prospects of the US Blockchain Pharmaceutical Supply Chain Management Market Industry as stakeholders strive for better transparency. ## **US Blockchain Pharmaceutical Supply Chain Management Market Segment Insights** ### **Blockchain Pharmaceutical Supply Chain Management Market Application Insights** The Application segment of the US Blockchain Pharmaceutical Supply Chain Management Market represents a critical aspect of the industry's shift towards increased transparency and efficiency. In light of the growing complexities in supply chains, product traceability has emerged as a dominant factor. Risk and compliance management also plays a crucial role in this market. Regulatory bodies are tightening their rules around drug safety and traceability, prompting pharmaceutical companies to adopt blockchain technology to not only meet compliance but also manage risks effectively. By providing real-time visibility into the supply chain, blockchain applications assist organizations in identifying potential issues before they escalate, thus safeguarding public health. Payment and settlement applications facilitate streamlined and secure transactions within the supply chain, acting as an enabler for faster settlements and reduced fraud. These applications significantly enhance the financial efficacy of the pharmaceutical sector, allowing companies to focus resources on innovation and development. Additionally, there are other applications that cater to unique needs within the industry, reflecting the versatility of blockchain technology. These solutions often focus on enhancing operational efficiencies or providing specialized capabilities that bolster the overall supply chain integrity. As companies progressively realize the benefits of blockchain, the various applications become integral components that support the shift towards a more secure and accountable pharmaceutical ecosystem. The US Blockchain Pharmaceutical Supply Chain Management Market is experiencing advancements that not only promise growth but also challenge traditional processes within the pharmaceutical industry. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Blockchain Pharmaceutical Supply Chain Management Market End User Insights** The End User segment of the US Blockchain Pharmaceutical Supply Chain Management Market holds significant importance as it encompasses key players such as Manufacturers, Distributors, and Healthcare Providers. Manufacturers play a crucial role as they are responsible for the production of pharmaceutical products, and the adoption of blockchain technology in this segment enhances traceability, reduces counterfeits, and ensures product integrity throughout the supply chain. As the market evolves, these end users drive demand for innovative solutions, greatly influencing market trends and growth. The integration of blockchain technology addresses challenges such as data interoperability and regulatory compliance, thus promising a more transparent and secure pharmaceutical supply chain in the US. ## **US Blockchain Pharmaceutical Supply Chain Management Market Key Players and Competitive Insights** The US Blockchain Pharmaceutical Supply Chain Management Market is increasingly becoming a focal point for innovation and technological advancements aimed at enhancing the traceability, efficiency, and security of pharmaceutical logistics. The market has witnessed a surge in interest from various stakeholders who recognize the potential of blockchain technology to address the challenges of counterfeit drugs, compliance with regulatory standards, and the need for real-time data sharing among supply chain participants. Analyzing the competitive landscape reveals an array of companies leveraging blockchain solutions to streamline operations, improve transparency, and foster trust in the supply chain ecosystem. Furthermore, strategic partnerships and collaborations are emerging as key trends, enabling companies to expand their service offerings and consolidate their market positions. SAP has established a robust presence in the US Blockchain Pharmaceutical Supply Chain Management Market by offering innovative solutions that integrate with existing enterprise resource planning systems. The company's strengths lie in its extensive expertise in software development and its established reputation among pharmaceutical giants. SAP’s approaches emphasize enhanced visibility into supply chain transactions, which are critical for regulatory compliance and risk mitigation. By providing a blockchain-enabled platform that ensures immutable record-keeping, SAP positions itself as a trusted partner for pharmaceutical companies looking to implement efficient supply chain solutions. Furthermore, its strong customer relationships across diverse sectors empower SAP to capitalize on emerging trends and address the complex demands of the pharmaceutical landscape in the US. Chronicled is a prominent player in the US Blockchain Pharmaceutical Supply Chain Management Market, known for its innovative approach to tackling supply chain integrity issues specifically within the pharmaceutical sector. The company offers key products and services, including a blockchain-based platform that fosters regulatory compliance and improves traceability of pharmaceutical products from manufacturers to end-users. Chronicled's strengths include its integrations with existing supply chain infrastructure and its focus on ensuring authenticity in drug distribution, positioning itself as a leader in maintaining supply chain integrity. The company's strategic initiatives, including partnerships for technology sharing and potential mergers, are aimed at expanding its reach and enhancing its service offerings. As the market evolves, Chronicled's commitment to leveraging blockchain technology equips it to effectively address the growing demands of the pharmaceutical supply chain ecosystem in the United States. ### **Key Companies in the US Blockchain Pharmaceutical Supply Chain Management Market Include** ### **US Blockchain Pharmaceutical Supply Chain Management Market Industry Developments** Recent developments in the US Blockchain Pharmaceutical Supply Chain Management Market have been significant, reflecting the increasing adoption of blockchain technology among major players like SAP, IBM, and Oracle. In September 2023, chronicled announced a collaboration with MediLedger to enhance supply chain traceability, leveraging blockchain solutions to ensure drug authenticity. The market saw a notable growth in valuation, with a reported increase of approximately 30% from fiscal year 2022 to 2023, attributed to an uptick in demand for transparency and security among pharmaceutical distributors. AstraZeneca and Pfizer have also invested in blockchain initiatives, focusing on improving efficiency in logistics and regulatory compliance. Noteworthy acquisitions occurred in July 2023, when Accenture acquired a blockchain-focused tech firm, aiming to expand its capabilities within the pharmaceutical sector. Additionally, Walgreens Boots Alliance partnered with VeChain in August 2023 to streamline inventory management through blockchain solutions, further highlighting the trend of major organizations leveraging technology for enhanced supply chain integrity. These developments showcase the growing integration of blockchain to address challenges in the pharmaceutical supply chain, including counterfeit drugs and operational inefficiencies. ## **US Blockchain Pharmaceutical Supply Chain Management Market Segmentation Insights** ### **Blockchain Pharmaceutical Supply Chain Management Market Application Outlook** ### **Blockchain Pharmaceutical Supply Chain Management Market End User Outlook** ## Market Drivers ### Enhanced Security Measures Security concerns surrounding the pharmaceutical supply chain are prompting a shift towards blockchain technology. The blockchain pharmaceutical-supply-chain-management market will benefit from the implementation of decentralized systems that enhance data security. By utilizing cryptographic techniques, blockchain can significantly reduce the risk of data breaches and counterfeiting. In fact, it is estimated that the cost of counterfeit drugs could reach $200 billion annually, underscoring the urgent need for secure solutions. As pharmaceutical companies seek to protect their intellectual property and ensure the integrity of their products, the adoption of blockchain technology appears to be a viable strategy to mitigate these risks. ### Increased Demand for Transparency The blockchain pharmaceutical-supply-chain-management market is experiencing heightened demand for transparency among stakeholders. This demand is driven by the need for reliable tracking of pharmaceuticals from production to delivery. As consumers and healthcare providers become more aware of the importance of drug authenticity, the market is likely to see a surge in blockchain solutions that provide immutable records. According to industry estimates, the market for blockchain in pharmaceuticals could reach $1.6 billion by 2025, reflecting a compound annual growth rate (CAGR) of approximately 48%. This trend indicates that stakeholders are increasingly prioritizing transparency, which is essential for building trust and ensuring patient safety. ### Regulatory Support and Initiatives Regulatory bodies in the US are increasingly recognizing the potential of blockchain technology in the pharmaceutical supply chain. The blockchain pharmaceutical-supply-chain-management market is likely to benefit from supportive regulations that encourage innovation and adoption. For instance, the FDA has shown interest in exploring blockchain applications to enhance drug traceability and safety. This regulatory backing could lead to increased investment in blockchain solutions, as companies seek to comply with evolving standards. As the market matures, it is anticipated that regulatory frameworks will become more defined, further driving the adoption of blockchain technologies in the pharmaceutical sector. ### Growing Focus on Supply Chain Efficiency The need for improved efficiency in the pharmaceutical supply chain is a significant driver for the blockchain pharmaceutical-supply-chain-management market. Companies are increasingly seeking solutions that streamline operations, reduce delays, and minimize costs. Blockchain technology offers the potential to automate various processes, thereby enhancing overall supply chain efficiency. Reports suggest that implementing blockchain could reduce supply chain costs by up to 30%, making it an attractive option for pharmaceutical companies. As the industry continues to evolve, the emphasis on operational efficiency is likely to propel the adoption of blockchain solutions. ### Rising Consumer Awareness and Demand for Authenticity Consumer awareness regarding the authenticity of pharmaceuticals is on the rise, influencing the blockchain pharmaceutical-supply-chain-management market. Patients and healthcare providers are increasingly concerned about counterfeit drugs and their implications for health. This growing awareness is driving demand for solutions that can verify the authenticity of medications throughout the supply chain. Blockchain technology, with its ability to provide a secure and transparent record of transactions, appears to be a promising solution. As consumers continue to prioritize safety and authenticity, the market for blockchain applications in pharmaceuticals is expected to expand significantly. ## Future Outlook The [Blockchain Pharmaceutical Supply Chain Management Market](https://www.marketresearchfuture.com/reports/blockchain-pharmaceutical-supply-chain-management-market-8009) is projected to grow at a compound annual growth rate (CAGR) of 21.07% from 2025 to 2035, driven by enhanced transparency, regulatory compliance, and operational efficiency. **New opportunities:** - Integration of IoT devices for real-time tracking of pharmaceuticals. Development of smart contracts to automate compliance processes. Creation of decentralized marketplaces for direct-to-consumer drug sales. By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic partnerships. ## Segment Insights ### By Application: Product Traceability (Largest) vs. Risk & Compliance Management (Fastest-Growing) In the US blockchain pharmaceutical-supply-chain-management market, Product Traceability holds the largest share among the application segments, showcasing its critical role in ensuring the authenticity and safety of pharmaceutical products. Following closely is Risk & Compliance Management, which is gaining significant traction as companies increasingly focus on regulatory requirements and risk mitigation in their supply chains. Both segments highlight the shift towards digital solutions in managing pharmaceutical logistics. The growth trends within this segment are fueled by the escalating demand for transparency and accountability in the supply chain. Regulatory pressures, alongside rising incidences of counterfeit drugs, are driving investment in blockchain technology. Moreover, the integration of smart contracts within Payment & Settlement processes is enhancing efficiency and security, thereby attracting more stakeholders to these emerging applications, ensuring robust development in the landscape. Product Traceability (Dominant) vs. Risk & Compliance Management (Emerging) Product Traceability is characterized by its ability to provide real-time data on the location and status of pharmaceutical goods throughout the supply chain, ensuring compliance with safety regulations and enabling prompt action against potential fraud. This dominant segment not only enhances the ability of companies to track products but also boosts consumer confidence in drug safety. Conversely, Risk & Compliance Management is emerging as a vital component in navigating the complexities of pharmaceutical regulations. This segment focuses on managing risk through comprehensive audits and adherence to compliance protocols, becoming increasingly integrated with other applications. The rise of data analytics and machine learning further aids in identifying risks, leading to smarter decision-making processes in compliance management. ### By End-User: Manufacturers (Largest) vs. Healthcare Providers (Fastest-Growing) In the US blockchain pharmaceutical-supply-chain-management market, manufacturers hold a dominant share, reflecting their crucial role in the supply chain. They leverage blockchain technology to enhance transparency and traceability, ensuring compliance and reducing counterfeiting risks. Meanwhile, healthcare providers, while currently smaller in market share, are witnessing significant adoption of blockchain solutions to streamline operations and improve patient outcomes. Growth trends indicate an increasing investment in blockchain technology among healthcare providers, driven by the need for improved data sharing and security. As regulatory pressures mount and the demand for efficient supply chains rises, healthcare providers are expected to emerge rapidly as a key segment in the market. Their focus on integrating blockchain solutions highlights their evolving role in the pharmaceutical supply chain. Manufacturers: Dominant vs. Healthcare Providers: Emerging Manufacturers represent the dominant force in the US blockchain pharmaceutical-supply-chain-management market, as they significantly benefit from enhanced operational efficiency and reduced risk of fraud through blockchain technologies. Their investments in this technology are geared towards improving production processes, ensuring regulatory compliance, and enhancing supply chain transparency. On the other hand, healthcare providers are considered an emerging segment, increasingly adopting blockchain solutions to address challenges such as data interoperability and secure patient information management. This shift is driven by their growing recognition of blockchain’s potential to transform healthcare delivery. As they navigate the complexities of patient data and seek to improve service delivery, healthcare providers are expected to become a pivotal player in the ongoing evolution of the pharmaceutical supply chain. ## Competitive Benchmarking The blockchain pharmaceutical-supply-chain-management market is currently characterized by a dynamic competitive landscape, driven by the increasing demand for transparency, traceability, and efficiency in drug distribution. Key players such as IBM (US), Chronicled (US), and MediLedger (US) are at the forefront, leveraging innovative technologies to enhance operational capabilities. IBM (US) focuses on integrating artificial intelligence and blockchain to streamline supply chain processes, while Chronicled (US) emphasizes partnerships with pharmaceutical companies to improve compliance and reduce counterfeiting. MediLedger (US) adopts a collaborative approach, working with various stakeholders to create a decentralized network that enhances data sharing and security. Collectively, these strategies foster a competitive environment that prioritizes technological advancement and operational efficiency.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to respond to market demands swiftly. The market structure appears moderately fragmented, with several players vying for market share, yet the influence of major companies is substantial. Their collective efforts in enhancing supply chain transparency and reliability are reshaping industry standards, indicating a shift towards more integrated and technology-driven operations. In October IBM (US) announced a strategic partnership with a leading pharmaceutical manufacturer to implement a blockchain-based solution aimed at improving drug traceability. This initiative is expected to enhance compliance with regulatory requirements and reduce the risk of counterfeit drugs entering the supply chain. The strategic importance of this partnership lies in its potential to set a new benchmark for industry standards in drug safety and transparency. In September Chronicled (US) launched a new platform that utilizes blockchain technology to facilitate real-time tracking of pharmaceuticals from production to delivery. This move is significant as it addresses the growing concerns regarding supply chain inefficiencies and counterfeit products. By providing stakeholders with real-time data, Chronicled (US) enhances trust and accountability within the supply chain, which is crucial for maintaining product integrity. In August MediLedger (US) expanded its network by integrating additional pharmaceutical companies into its blockchain ecosystem. This expansion is pivotal as it not only increases the network's robustness but also enhances data sharing capabilities among participants. The strategic importance of this move lies in its ability to foster collaboration and innovation, ultimately leading to improved supply chain efficiency and reliability. As of November current competitive trends in the blockchain pharmaceutical-supply-chain-management market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances among key players are shaping the landscape, facilitating knowledge sharing and resource optimization. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of adopting cutting-edge solutions to meet the evolving demands of the pharmaceutical industry. ## Recent News & Developments Recent developments in the US Blockchain Pharmaceutical Supply Chain Management Market have been significant, reflecting the increasing adoption of blockchain technology among major players like SAP, IBM, and Oracle. In September 2023, chronicled announced a collaboration with MediLedger to enhance supply chain traceability, leveraging blockchain solutions to ensure drug authenticity. The market saw a notable growth in valuation, with a reported increase of approximately 30% from fiscal year 2022 to 2023, attributed to an uptick in demand for transparency and security among pharmaceutical distributors. AstraZeneca and Pfizer have also invested in blockchain initiatives, focusing on improving efficiency in logistics and regulatory compliance. Noteworthy acquisitions occurred in July 2023, when Accenture acquired a blockchain-focused tech firm, aiming to expand its capabilities within the pharmaceutical sector. Additionally, Walgreens Boots Alliance partnered with VeChain in August 2023 to streamline inventory management through blockchain solutions, further highlighting the trend of major organizations leveraging technology for enhanced supply chain integrity. These developments showcase the growing integration of blockchain to address challenges in the pharmaceutical supply chain, including counterfeit drugs and operational inefficiencies. ## Report Scope | MARKET SIZE 2024 | 253.13(USD Million) | | --- | --- | | MARKET SIZE 2025 | 306.47(USD Million) | | MARKET SIZE 2035 | 2074.72(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 21.07% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | IBM (US), Modum (CH), Chronicled (US), VeChain (CN), Waltonchain (CN), MediLedger (US), Acoer (US), PharmaLedger (EU) | | Segments Covered | Application, End-User | | Key Market Opportunities | Integration of blockchain technology enhances traceability and security in pharmaceutical supply chains. | | Key Market Dynamics | Rising regulatory scrutiny drives blockchain adoption for enhanced transparency in pharmaceutical supply chains. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the current market valuation of the US blockchain pharmaceutical-supply-chain-management market?** A: The market valuation was $253.13 Million in 2024. **Q: What is the projected market size for the US blockchain pharmaceutical-supply-chain-management market by 2035?** A: The projected market size is $2074.72 Million by 2035. **Q: What is the expected CAGR for the US blockchain pharmaceutical-supply-chain-management market during 2025 - 2035?** A: The expected CAGR is 21.07% during the forecast period. **Q: Which application segments are driving growth in the US blockchain pharmaceutical-supply-chain-management market?** A: Key application segments include Product Traceability, Risk & Compliance Management, and Payment & Settlement. **Q: What was the valuation of the Product Traceability segment in 2024?** A: The Product Traceability segment was valued at $80.0 Million in 2024. **Q: How much is the Risk & Compliance Management segment projected to be worth by 2035?** A: The Risk & Compliance Management segment is projected to reach $500.0 Million by 2035. **Q: Who are the key players in the US blockchain pharmaceutical-supply-chain-management market?** A: Key players include IBM, Modum, Chronicled, VeChain, Waltonchain, MediLedger, Acoer, and PharmaLedger. **Q: What is the valuation of the Healthcare Providers segment in 2024?** A: The Healthcare Providers segment was valued at $102.35 Million in 2024. **Q: What is the projected valuation for the Distributors segment by 2035?** A: The Distributors segment is projected to be worth $600.0 Million by 2035. **Q: How does the market performance of the US blockchain pharmaceutical-supply-chain-management compare across different end-users?** A: Manufacturers, Distributors, and Healthcare Providers show varying valuations, with Healthcare Providers leading at $804.72 Million in 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-blockchain-pharmaceutical-supply-chain-management-market-19314*